Studies of afferent lymph veiled cells (ALVC) show that the full biological
function of dendritic cells in peripheral tissue is not explained by a sim
ple model in which immature dendritic cells at the body surface take up ant
igen, migrate via the afferent lymph ducts, mature and then effectively pre
sent antigens to T-cells in the draining lymph node. Furthermore, it is evi
dent from various investigations that the dendritic cells in afferent lymph
, draining from the body surfaces are not a homogeneous population of cells
. They comprise a mixture of cell phenotypes defined by staining with monoc
lonal antibodies, and the different sub-populations have distinct biologica
l functions and roles in vivo. The molecular basis for differences between
the function of afferent lymph dendritic cell subsets is only now being exp
lored and defined but some progress has been made in understanding the role
of co-stimulatory molecules. It should be possible to exploit knowledge of
the functions of these cells and aid future vaccination strategies in dome
sticated animals thereby improving animal health and reducing economic loss
, and, as a consequence, improving human health. By deliberately targeting
functionally distinct subsets of either precursor or mature dendritic cells
in vivo, it should become feasible to achieve an appropriately biased immu
ne response. (C) 2000 Elsevier Science B.V. All rights reserved.